OncUpdates

1.3K posts

OncUpdates banner
OncUpdates

OncUpdates

@OncUpdates

Latest oncology insights for medical professionals and patients | curating cancer news, trials, & advances in cancer care |Own Views| Not medical advice

Worldwide Katılım Kasım 2024
702 Takip Edilen794 Takipçiler
OncUpdates retweetledi
Chinmay Jani
Chinmay Jani@Jani_Chinmay·
As we get ready for #ASCO26, sharing our recent article on first-line EGFR-mutant NSCLC. We provide a detailed review of data across PFS and OS, along with key subgroup analyses, to help inform more personalized treatment decisions for patients with stage IV EGFR-positive NSCLC.#Flaura2 #Mariposa @GlopesMd @SylvesterCancer @RuchiJani27 @OncUpdates @EGFRResisters
OncUpdates@OncUpdates

🚨 Beyond Osimertinib Monotherapy: Frontline Intensification in EGFR+ #NSCLC 🫁 👉FLAURA2 & MARIPOSA both show OS benefit with upfront combos vs osimertinib alone. #OncTwitter #lcsm #MedTwitter @HemOncMiami 🤩 @Jani_Chinmay breaks down these 🔑studies👇 oncupdates.com/article/beyond…

English
0
4
13
1.5K
OncUpdates retweetledi
Oncology Brothers
Oncology Brothers@OncBrothers·
Here is the table we have used during our ToxCheck discussion w/ @MLJohnsonMD2 on BRAF-MEKi. - Common AEs - Approved dose/Step down dosing - Clinical Pearls #OncTwitter #MedTwitter #lcsm @OncUpdates @OncoAlert
Oncology Brothers tweet media
Oncology Brothers@OncBrothers

ToxCheck: BRAF-MEKi in #LungCancer with @MLJohnsonMD2 ✅ Encorafenib-Binimetinib ✅ Dabrafenib-Trametinib Full 🗣️ ⭐️ OncBrothers & @OncUpdates Website ⭐️ “Oncology Brothers” podcast #OncTwitter #MedTwitter @SarahCannonDocs @OncoAlert

English
5
7
28
3.8K
OncUpdates retweetledi
Stephanie A. Haddad, DO
Stephanie A. Haddad, DO@DrSAHaddad·
Thrilled to be selected as an #ASCO26 Featured Voice! Looking forward to sharing insights and connecting with colleagues advancing cancer care and research #Oncology #CancerCare @ASCO @mayscancer @LSOM_HemOnc @HemOncFellows @oncodaily @OncUpdates
ASCO@ASCO

We’re pleased to announce our Featured Voices for #ASCO26! Get their expert insights into the science & ed sessions, what they view as practice changing & how to bring the learning into the clinic. Be a part of the conversation using the meeting hashtag. bit.ly/42Oaats

English
3
3
22
631
Nicholas Hornstein
Nicholas Hornstein@GIMedOnc·
ITS STARTING #ASCO26 Very excited to share that I’ll be serving as a Voice of ASCO this year. ASCO is always one of the most important weeks of the year in oncology, not just because of the new data, but because of the context around it. What changes practice? What is interesting but not ready yet? Where are the tradeoffs? Where do we need to be careful not to overinterpret? I’ll be focusing mostly on GI oncology, highlighting key studies, new data, clinical context, strengths and limitations, and what it may mean for patients and oncologists. Looking forward to learning from and engaging with so many great colleagues throughout the meeting. See you all at ASCO. @NazliDizman @LauraAlderMD @DVAraujoMD @DrBarbiOnc @LauraEsfeller @FunchainMD @YGaritaonaindia @DrSAHaddad @jgong15 @iandresmeraz @SakditadMD @RamilaShilpakar @RohitBanwar @lungoncdoc @ASCO @NorthwellHealth @Onco_Nexus @OncoAlert
ASCO@ASCO

We’re pleased to announce our Featured Voices for #ASCO26! Get their expert insights into the science & ed sessions, what they view as practice changing & how to bring the learning into the clinic. Be a part of the conversation using the meeting hashtag. bit.ly/42Oaats

English
4
13
57
3.2K
OncUpdates retweetledi
Eric K. Singhi, MD
Eric K. Singhi, MD@lungoncdoc·
#ASCO26 is almost here!! Thrilled to be a featured voice for the conference. Follow along as I share the latest updates in lung cancer research. @ASCO
ASCO@ASCO

We’re pleased to announce our Featured Voices for #ASCO26! Get their expert insights into the science & ed sessions, what they view as practice changing & how to bring the learning into the clinic. Be a part of the conversation using the meeting hashtag. bit.ly/42Oaats

English
2
10
41
3K
OncUpdates
OncUpdates@OncUpdates·
🚨@ASCO GI Abstracts to Watch 👀 ⭐️RASolute 302: daraxonrasib vs chemo in mPDAC ⭐️HERIZON-GEA-01:PD-L1 subgroup data ⭐️BREAKWATER +SWOG S2107 : IO + chemo backbone in BRAF V600E mCRC ⭐️CIRCULATE: ctDNA-guided adjuvant in stage II colon cancer #OncTwitter oncupdates.com/article/asco-2…
English
0
1
1
130
OncUpdates retweetledi
Oncology Brothers
Oncology Brothers@OncBrothers·
We have 2 BRAF/MEKi combinations available in BRAF-V600E NSCLC. Cross trial comparison 👇 is not fair because different mature data points that are available. But AEs can help pick one over the other. #lcsm #LungCancer #OncTwitter #MedTwitter @OncUpdates
Oncology Brothers tweet media
Oncology Brothers@OncBrothers

Here is the link to our full discussion on Treatment Algorithm BRAF-V600E NSCLC with @RielyMD ✅ Prevalence ✅ Data for BRAF/MEKi or IO ✅ Sequencing #OncTwitter #lcsm @OncoAlert @OncUpdates youtu.be/zf2SjL5uNEY?si…

English
2
15
23
4.7K
OncUpdates retweetledi
Oncology Brothers
Oncology Brothers@OncBrothers·
Treatment Algorithm: Focused discussion around BRAF-V600E metastatic NSCLC with @RielyMD ✅ Prevalence ✅ BRAF + MEKi ✅ IO or IO + Chemo ✅ Sequencing Full 🗣️: ⭐️ OncBrothers & @OncUpdates Website ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #lcsm #MedTwitter
English
1
11
19
1.7K
OncUpdates retweetledi
Oncology Brothers
Oncology Brothers@OncBrothers·
To summarize a few key points (thanks @myelomatips @hhashmi87 @RahulBanerjeeMD @JanakiramMurali for weighing in): - Prophylactic IVIG for all with BCMA Bsabs - Prophylactic Toci (if you can get it approved) - GPRC5D has different AEs - Updated table 👇👇 #mmsm #HemeTwitter
Oncology Brothers tweet media
Oncology Brothers@OncBrothers

We have 4 Bispecific Abs ✅ for Multiple Myeloma. Here is that list! We touched on common AEs, clinical pearls in managing them, role of prophylactic Toci & IVIG @hhashmi87 & @myelomatips ✅ Talquetamab ✅ Teclistamab ✅ Elranatamab ✅ Linvoseltamab #mmsm #HemeTwitter

English
2
14
42
7.9K
IASLC
IASLC@IASLC·
Congrats🎉to former IASLC Board Member and former IASLC President @HwakeleeMD on this momentous honor! Your leadership and contributions to the global thoracic oncology community continue to make a lasting impact.
Stanford Cancer Institute@StanfordCancer

We are proud to celebrate Heather Wakelee, Deputy Director of the Stanford Cancer Institute, for being named a 2026 Giant of Cancer Care in the Thoracic Malignancies category. brnw.ch/21x2qPy @HwakeleeMD @MJHLifeSciences

English
3
6
29
2.8K

Keşfet

@GlopesMd @SylvesterCancer @RuchiJani27 @EGFRResisters @MLJohnsonMD2 @OncoAlert @DrSAHaddad @ASCO